Reports for RANBAXY PHARMACEUTICALS CANADA INC.
Company Name
RANBAXY PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
60 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 60 (100%) | |
Discontinuation Reports |
28 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 28 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
39 (44%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-METFORMIN | 500MG | TABLET | Resolved | 2019-11-08 | 2019-11-26 | 98306 |
| RAN-EZETIMIBE | 10MG | TABLET | Resolved | 2020-01-20 | 2020-03-07 | 103675 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-20 | 2020-02-02 | 103678 |
| RAN-CITALO | 20MG | TABLET | Resolved | 2020-02-02 | 2020-03-07 | 105121 |
| RAN-CITALO | 20MG | TABLET | Resolved | 2020-02-02 | 2020-03-07 | 105124 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-02-02 | 2020-03-07 | 105127 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2020-05-27 | 2020-10-28 | 115893 |
| RAN-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-06-01 | 2020-12-03 | 116289 |
| RAN-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-11-06 | 2020-12-03 | 127955 |
| RAN-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-11-06 | 2020-12-03 | 127960 |
| RAN-ROPINIROLE | 5.0MG | TABLET | Resolved | 2020-12-03 | 2021-07-13 | 129547 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132979 |
| RAN-ROPINIROLE | 2.0MG | TABLET | Resolved | 2021-10-21 | 2021-11-26 | 147748 |
| RAN-EZETIMIBE | 10MG | TABLET | Resolved | 2022-01-06 | 2022-02-15 | 152160 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2022-01-06 | 2022-02-15 | 152163 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2022-04-12 | 2024-05-09 | 158553 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2022-08-19 | 2022-11-25 | 167426 |
| RAN-ROPINIROLE | 2.0MG | TABLET | Resolved | 2022-08-19 | 2024-05-09 | 167429 |
| RAN-ROPINIROLE | 5.0MG | TABLET | Resolved | 2022-08-19 | 2024-05-09 | 167432 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2022-12-13 | 2024-05-09 | 178240 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91281 |
| RAN-FENTANYL MATRIX PATCH | 12MCG | PATCH | Discontinued | 2019-09-03 | 2019-09-03 | 92856 |
| RAN-METFORMIN | 500MG | TABLET | Discontinued | 2019-11-26 | 2019-11-26 | 99750 |
| RAN-METFORMIN | 850MG | TABLET | Discontinued | 2019-11-26 | 2019-11-26 | 99755 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-02-02 | 2020-02-02 | 105096 |
| RAN-CITALO | 20MG | TABLET | Discontinued | 2020-03-07 | 2020-03-07 | 108124 |
| RAN-CITALO | 20MG | TABLET | Discontinued | 2020-03-07 | 2020-03-07 | 108127 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-03-07 | 2020-03-07 | 108130 |